Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of the Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

NCT06560021 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT06560021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06560021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of the Utility of Random Biopsies in Patients With Inflammatory Bowel Disease
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 3, 2025
Completion date
June 30, 2029
Enrollment
1,642 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, inflammatory bowel diseases, ulcerative colitis